Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2022 call → NOWe need to determine if management explains where the company's business is going by narrating what its counterparties are themselves doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. Management discusses various channels: food, club, mass. They talk about distribution gains, new points of distribution, retailer resets, etc. But do they narrate specific counterparties' own trajectories? For example, they mention "one of the two major players nationwide" in mass channel, moving from five flavors to 12 flavors, and from six packs to eight packs. They also mention "the other top mass retailer" taking on kids flavors. They talk about club channel growth, with almost 250,000 incremental households. But is that describing the counterparties' own expansion? Or is it describing Zevia's own distribution gains? The question is about whether management is reporting on somebody else's growth as the reason for its own. For instance, if a retailer is expanding its stores or rolling out a program, and Zevia is supplying that, then that would be a counterparty trajectory. But here, management talks about Zevia's own distribution gains, new points of distribution, and retailer acceptance. They mention "we await fall resets to open new opportunities there" - that's about Zevia's own selling effort. They talk about "strong velocity in our existing footprint." They talk about their own pricing actions, promotional optimization, cost initiatives. The forward account is largely about Zevia's own actions: pricing, innovation, marketing, distribution expansion. They do mention specific retailers but not in terms of those retailers' own scaling plans.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.